Le Lézard
Classified in: Health
Subjects: CCA, FVT

Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call


ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

Participant Dial-in Numbers: (877) 858-9810 or (201) 689-8517

To access the call, please dial in approximately five minutes before start time. An accompanying slide presentation will be available in PDF format on the "IR Calendar" page of the Company's website (https://www.apollomed.net/investors/news-events/ir-calendar) after issuance of the earnings release.

Webcast
The call will also be available via online webcast at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=EM7HqFSl 

Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

About Apollo Medical Holdings, Inc.

ApolloMed is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.

FOR MORE INFORMATION, PLEASE CONTACT:

Investor Relations
Asher Dewhurst
[email protected]

SOURCE Apollo Medical Holdings, Inc.


These press releases may also interest you

at 15:17
Biolexis Therapeutics, Inc. a clinical-stage AI-driven biopharmaceutical company, today announced it will present a late-breaking poster at the 2024 American Association of Immunologists (AAI), taking place May 3-7, 2024, in Chicago, IL....

at 15:16
AdventHealth Ocala and AdventHealth Carrollwood, along with all AdventHealth hospitals in Pasco County, including AdventHealth Wesley Chapel, AdventHealth Dade City and AdventHealth Zephyrhills, have once again earned an "A" Hospital Safety Grade...

at 15:05
Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that the Company will be presenting two posters sharing new preclinical data...

at 15:00
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) with the clearance of its uMR Jupiter 5T MRI system. This...

at 15:00
Pivot Bio, a leading sustainable agriculture company, announced today the appointment of industry veteran Chris Turner as Chief Commercial Officer. In this executive role, Turner will lead the company's global growth agenda and commercial sales...

at 14:52
Dr. Robert Bastian, renowned laryngologist and founder of Bastian Voice Institute (BVI), achieves a major milestone on May 1, 2024. Kicking off National Digestive Diseases Awareness Month, Dr. Bastian will treat his 1,000th patient with the diagnosis...



News published on and distributed by: